Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -2.100% | -61.326% | -61.111% | -46.970% | -37.500% | -84.358% | - |
| Fate Therapeutics Inc. | -1.880% | -14.595% | -26.874% | -16.608% | 33.296% | -93.009% | - |
| Viracta Therapeutics Inc. | 4.140% | - | - | - | - | - | - |
| Adaptimmune Therapeutics PLC ADR | -2.960% | -30.165% | -36.940% | -33.465% | 35.200% | -79.490% | - |
| Vanda Pharmaceuticals | -5.560% | 17.000% | 33.714% | -17.895% | 20.619% | -65.075% | - |
| ProQR Therapeutics N.V. | 1.020% | -3.022% | -9.833% | 3.112% | 14.749% | -58.920% | - |
| Deciphera Pharmaceuticals | -3.650% | -7.042% | -2.798% | -5.138% | -10.174% | -64.894% | - |
| Voyager Therapeutics Inc | -4.190% | -11.968% | -15.263% | 1.329% | -8.868% | 90.157% | - |